Precision NeuroMed’s team is growing! We’re happy to announce that Martin Brady, PhD is joining us as our VP of Clinical Software & Applications. This is a step forward in seamlessly integrating our software into the PNM delivery platform. Dr. Martin Brady is an experienced leader in the biotech industry, known for his contributions to the development of advanced therapeutic strategies. He earned his PhD in electrical engineering from the University of Illinois and Urbana-Champaign in the area of CAD algorithms for VLSI design. With a background in drug delivery systems and neurotherapeutics, Martin has played a pivotal role in advancing innovative solutions aimed at improving treatments for neurological disorders.
At Therataxis, a company specializing in precision drug delivery for the brain, Martin was Co-Founder and instrumental in driving operational efficiency, overseeing research collaborations, and ensuring the successful translation of scientific innovations into clinical applications. During his tenure, he played a significant role in gaining FDA clearance of their software. His expertise spans drug delivery, biomedical engineering, and neuroscience, making him a key player in pushing the boundaries of therapeutic interventions for brain diseases. His exceptional background coupled with his incredible scientific contributions makes him a crucial member of our company, as we pioneer a new forefront of drug delivery for neurological diseases.